# CorneaGen - Boston – FDA Inspection, Dec 20, 2024

Source: https://www.keypedia.com/records/fda_inspections/corneagen-boston/43ca6f6d-9fc0-4574-8a2c-ae5be00b98c8
Source feed: FDA_Inspections

> FDA inspection 1257221 of CorneaGen - Boston, December 20, 2024. 2 citations under 21 CFR part 1271. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1257221
- Company Name: CorneaGen - Boston
- Inspection Date: 2024-12-20
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: New England District Office
- Citation Count: 2

## Related Documents

- [FDA Inspection 1207719 - 2023-06-09](https://www.keypedia.com/records/fda_inspections/corneagen-boston/1eb901f6-19b0-405f-8bab-144f6e931eea)
- FDA Inspection 1121216 - 2020-03-05
- FDA Inspection 1068364 - 2018-09-12
- FDA Inspection 941531 - 2015-08-20
- [FDA Inspection 824487 - 2013-03-28](https://www.keypedia.com/records/fda_inspections/corneagen-boston/25aa4223-7973-4e2e-b56f-2b10ebc7d2d0)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/anthony-n-onianwa/910dd164-8542-4259-b11f-ea3a3f6d7baa)

Company: https://www.keypedia.com/companies/corneagen-boston/78964c02-d403-4377-8609-2434e1adaef8

Office: https://www.keypedia.com/offices/new-england-district-office/aa458072-2f1d-4231-89f5-21ba7a3b7144